New Delhi, Dec 26 (IANS) A new non-invasive therapy has shown promise and may benefit patients with hepatocellular carcinoma (HCC) — the most common type of primary liver cancer — in India. Globocan India 2020 reports more than 30,000 new local cases of hepatocellular carcinoma (HCC) are diagnosed every year, making it the 10th most common cause of cancer in India. Its high mortality rate makes it the eighth most common cause of cancer related deaths in the country. The common causes and risk factors for HCC in India include cirrhosis, hepatitis B and C infection, alcohol, smoking, diabetes, and non-alcoholic fatty liver disease. HCC can be treated with surgical resection and using minimally
Hence then, the article about new non invasive therapy shows promise for liver cancer patients was published today ( ) and is available onNews room odisha ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( New non-invasive therapy shows promise for liver cancer patients )